COVID-19 UPDATE read more

About NavRax Pharmaceuticals UK

NavRax Pharmaceuticals is a European-based specialty pharmaceutical company
with global reach and is a committed player in the treatment of
pain, addiction and critical care.

In the UK we are recognised as a key partner to the NHS
and the private hospital sector with our range of quality products.

Most of the products are made in our UK manufacturing facilities
in Romford and in our French manufacturing facilities in
Grand-Quevilly and Châteauneuf-en-Thymerais.

Patients & members of public

Our starting point is always the patient.

We offer high quality life-improving medicines
which make a difference to patients’ lives.

learn more

Healthcare Professionals

We have a strong heritage of supporting healthcare
professionals in the UK in both primary and secondary care settings.

Discover our extensive range of products
which reach across many therapeutic areas.

learn more

Orlins Pharma

A leading specialty pharmaceutical company with a strong heritage, based in the UK.
NavRax Pharmaceuticals acquired Orlins Pharma in January 2017/2018.

learn more

manufacturing

NavRax Pharmaceuticals in the UK manufactures high quality medicines, with the capability to supply products around the world. Discover our facilities in the UK

learn more

in-licensing

NavRax Pharmaceuticals is actively seeking In-licensing and partnership opportunities in the fields of pain, addiction and critical care to meet unmet medical needs Contact us

learn more

careers

Set your talents free at NavRax Pharmaceuticals!

Paul Concannon - UK Commercial Director

Portrait

discover our job opportunities

If you want further information, contact us

Email us at info@navrax-pharmaceuticals.com
or call +44 (0) 7520 631 193

Report Adverse Events

Reporting forms and information can be sent to :
info@navrax-pharmaceuticals.com

Adverse events should also be reported to NavRax Pharmaceuticals UK

Telephone : +44 (0) 7520 631 193
info@navrax-pharmaceuticals.com

Healthcare professionals’ medical information

Any personal data you share with us will remain confidential at all times.

Medical enquiries can be directed to the Medical Information department at:

By clicking on this link, you agree to leave our website.
Are you sure?

NO YES

FREQUENTLY ASKED QUESTIONS

select products

PRODUCTSREQUESTS

Abtard®

Are there bioequivalence data with OxyContin?
Yes, data from twelve bioequivalence studies comparing Abtard with the reference product were submitted in support of the application for Marketing Authorisation.
How do I store Abtard® tablets?
We do not have information on the stability of Abtard® tablets outside of the original packaging. Abtard® tablets must be stored below 25°C in the original packaging to protect from moisture.
Is Abtard Monophasic or biphasic?
Abtard prolonged -release tablets are bioequivalent to OxyContin prolonged-release tablets and are biphasic, meaning that there is an initial absorption of approximately 40% of oxycodone from the tablet providing onset of analgesia within one hour in most patients, followed by a more controlled absorption, which determines the 12-hour duration or action.
How do I take Abtard® tablets?
Abtard® tablets must be taken as directed by your doctor or pharmacist. Abtard® tablets must be swallowed whole with a sufficient amount of liquid and not chewed.
Are the tablets film coated?
Yes they are
Are 2 x 60mg tablets bioequivalent to a single 120mg strength of OxyContin?
There are no bioequivalence studies for Abtard 2 x 60mg versus one single dose of 120mg of OxyContin. It is a matter of clinical judgement for the prescriber to decide whether 2 x 60 mg tablets can be used. What the bioequivalence studies prove is that Abtard 60mg is bioequivalent to OxyContin 60mg. In practice if a retail pharmacist received a prescription for 120mg of OxyContin and only had the 60mg OxyContin available would they give 2 x 60mg tablets

DIDN'T FIND WHAT YOU WERE LOOKING FOR?
Please feel free to contact us for any further question. Please note that we are unable to provide medical advice.
Contact: medinfo@martindalepharma.co.uk

HOW MUCH COULD YOU SAVE ?

CHOOSE YOUR CCG

TOTAL CCG
SAVINGS across our products

£0.00

CHOOSE A PRACTICE NAME

TOTAL PRACTICE
SAVINGS across our products

£0.00

England & Wales
The data in this dashboard includes General Practice Prescribing Data - NHS prescriptions that are prescribed in England & Wales by GPs, and non medical prescribers that have prescribed on behalf of the GP practice, that are then dispensed in the community.

NHS Prescription Services, part of the NHS Business Services Authority (BSA), is the provider of the England data and NHS Wales Shared Partnerships Services is the provider of the Wales data.

This public sector information is licensed under the Open Government Licence v3.0.

The cost model compares NavRax Pharmaceuticals products to alternative products. Only comparable doses of alternative products, which can be clearly identified in the NHS prescription data, are used in the model.

Scotland
The data in this dashboard includes General Practice Prescribing Data - NHS prescriptions that are prescribed in Scotland by GPs, and non medical prescribers that have prescribed on behalf of the GP practice, that are then dispensed in the community.

ISD, NHS Scotland is the provider of the data.

This public sector information is licensed under the Open Government Licence v3.0.

The cost model compares NavRax Pharmaceuticals products to alternative products. Only comparable doses of alternative products, which can be clearly identified in the NHS prescription data, are used in the model.